$12.00
1.15% yesterday
Nasdaq, Oct 23, 10:00 pm CET
ISIN
US03475V1017
Symbol
ANGO

AngioDynamics, Inc. Stock price

$12.00
+1.21 11.21% 1M
+2.65 28.34% 6M
+2.84 31.00% YTD
+4.86 68.07% 1Y
-1.07 8.19% 3Y
+0.93 8.40% 5Y
-0.07 0.58% 10Y
-10.58 46.86% 20Y
Nasdaq, Closing price Thu, Oct 23 2025
-0.14 1.15%

Key metrics

Basic
Market capitalization
$494.4m
Enterprise Value
$461.7m
Net debt
positive
Cash
$38.8m
Shares outstanding
41.5m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.6 | 1.6
EV/Sales
1.5 | 1.5
EV/FCF
negative
P/B
2.8
Financial Health
Equity Ratio
65.3%
Return on Equity
-18.6%
ROCE
-11.9%
ROIC
-12.5%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$300.7m | $314.2m
EBITDA
$-13.1m | $5.5m
EBIT
$-23.5m | $-30.2m
Net Income
$-32.1m | $-13.1m
Free Cash Flow
$-11.9m
Growth (TTM | estimate)
Revenue
2.7% | 7.4%
EBITDA
39.1% | 138.9%
EBIT
29.9% | -24.1%
Net Income
86.8% | 61.4%
Free Cash Flow
55.3%
Margin (TTM | estimate)
Gross
54.2%
EBITDA
-4.4% | 1.7%
EBIT
-7.8%
Net
-10.7% | -4.2%
Free Cash Flow
-4.0%
More
EPS
$-0.8
FCF per Share
$-0.3
Short interest
7.0%
Employees
748
Rev per Employee
$390.0k
Show more

Is AngioDynamics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,021 stocks worldwide.

AngioDynamics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a AngioDynamics, Inc. forecast:

9x Buy
90%
1x Hold
10%

Analyst Opinions

10 Analysts have issued a AngioDynamics, Inc. forecast:

Buy
90%
Hold
10%

Financial data from AngioDynamics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Aug '25
+/-
%
301 301
3% 3%
100%
- Direct Costs 138 138
2% 2%
46%
163 163
8% 8%
54%
- Selling and Administrative Expenses 149 149
5% 5%
50%
- Research and Development Expense 26 26
12% 12%
9%
-13 -13
39% 39%
-4%
- Depreciation and Amortization 10 10
13% 13%
3%
EBIT (Operating Income) EBIT -23 -23
30% 30%
-8%
Net Profit -32 -32
87% 87%
-11%

In millions USD.

Don't miss a Thing! We will send you all news about AngioDynamics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

AngioDynamics, Inc. Stock News

Neutral
Business Wire
11 days ago
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced that its NanoKnife System has been selected as one of TIME's 2025 Best Inventions. The annual list celebrates groundbreaking products and te...
Positive
Seeking Alpha
22 days ago
AngioDynamics, Inc. remains a Buy, trading at a steep discount to peers despite double-digit MedTech growth and improving margins. ANGO's Med Tech division now drives 47% of sales, with strong performance from Auryon, AlphaVac, AngioVac, and NanoKnife products. Gross margin improved to 55.3%, operating costs are under control, and management expects positive cash flow and raised guidance for FY...
Positive
The Motley Fool
22 days ago
AngioDynamics (ANGO 7.00%) stock soared 10.5% through 11:25 a.m. ET Thursday after beating on "earnings" (sort of) this morning.
More AngioDynamics, Inc. News

Company Profile

AngioDynamics, Inc. engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage. thrombolytic, and venous products. The company was founded by Eamonn P. Hobbs in 1988 and is headquartered in Latham, NY.

Head office United States
CEO James Clemmer
Employees 748
Founded 1988
Website www.angiodynamics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today